Input 2020.12.30 09:14
It is reported that AstraZeneca, a British pharmaceutical company, has not yet applied to the European Medicines Agency (EMA) for approval of the use of a novel coronavirus infection (Corona 19) vaccine. Accordingly, it is predicted that it will be difficult to distribute the vaccine in Europe in January next year.
Noel Wattion, deputy director of the European Medicines Agency (EMA), said in an interview with Het Newsblad in Belgium on the 29th (local time), “AstraZeneca has not yet submitted an application.” “We need more data on this.” So, for now, the AstraZeneca vaccine is unlikely to receive EMA approval next month.
Earlier, the British government announced that it plans to start vaccinating with AstraZeneca vaccine from January 4 next year. “We don’t know what data AstraZeneca sent to the British authorities, but there is a possibility of getting temporary approval,” said Wation.
It is reported that AstraZeneca has not yet applied for approval for use by the US Food and Drug Administration (FDA). The U.K. Drug and Health Management Product Regulatory Authority (MHRA) has formally applied for emergency use approval, but there is no news of approval yet.